Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
PeoplesBank and Nymbus Set New Standards in Employer-Focused Financial Solutions
-
CroíValve Announces First Implant of a Novel Minimally Invasive Device for Tricuspid Regurgitation in US Early Feasibility Study
-
In New IEEE Global Survey, Twice as Many Technologists Expect AI to be the Most Important Tech in 2025 Compared to Other Areas
-
Hormel Foods Recognized for Having One of the Nation's Top Internship Programs
-
Hanmi Financial Declares Cash Dividend of $0.25 per share
-
Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem
-
LifeMD® to Report Third Quarter 2024 Financial Results on November 7
-
Blue Sage Capital Invests In MHW
-
Redfin Reports Homebuying Demand Holds Up Even As Election Uncertainty, Stronger-Than-Expected Economy Push Up Rates
-
The Big Lots Foundation Pledges $200,000 to Support Hurricanes Helene and Milton Relief and Recovery Efforts
-
Trinasolar delivers over 1 GW of Vertex N 720W series modules to plateau PV project
-
Schneider Electric Partners with United Solar Initiative to Install Microgrids at Maternal Healthcare Clinics in Guatemala
-
Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Disea
-
Sinaptica Therapeutics to Present Results of 52-week Phase 2 Study of Precision Neuromodulation for Alzheimer’s Diseases in Oral Presentation at Clinical Trials on Alzheimer’s Disease (CTAD) Confe
-
National Tree Co. Study Finds Strong Holiday Décor Demand Persists Despite Inflation Concerns
-
SeekIn Presents Cost-Effective Two-Step Multi-Cancer Screening Strategy and Breakthrough Lung Cancer Early Detection Test at Early Detection of Cancer Conference in San Francisco
-
Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity
-
Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives
-
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
-
Cognosos Announces Acquisition of Cox Prosight to Enhance Real-Time Location Intelligence Solutions for Hospitals
-
Lateral Investment Management to Attend SuperReturn North America 2024
-
4imprint® Completes Expansion of Oshkosh Distribution Center
-
Cellino Appoints Chris Gibson to Board of Directors
-
Altium to Unveil Groundbreaking Industry Solution at Electronica 2024
-
Javelin Venture Partners Announces New Partners in $125 Million Fifth Fund
-
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
-
Ebb Carbon Signs Deal With Microsoft for CO2 Removal
-
Renesas Collaborates with Intel on Best-in-Class Power Management Solution for New Intel Core Ultra 200V Series Processors
-
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
-
Golden State Pops Orchestra presents the 2024 Holiday Pops Spectacular!
-
REX Shares and Tuttle Capital Management Launch Target 2X Leveraged and Inverse Ether ETP
-
ZenaTech's AI Drone Company Acquires Drone Design Patent From Former Parent Company
-
Krispy Kreme, Inc. to Announce Third Quarter 2024 Results on November 7, 2024
-
Installed Building Products to Report Third Quarter 2024 Financial Results
-
New Metron WaterMasters™ Full-Service Monitoring Levels Up Water Management for Real Estate Companies, Utilities
-
Inc. Names Pipeliner CRM as a 2024 Power Partner Award Winner
-
86% of Educators Say Gaps in Data Hinder Their Ability to Drive Academic Success and Curb Chronic Absenteeism, National Survey Reveals
-
Ranpak to Hold Conference Call to Discuss Third Quarter 2024 Results
-
WisdomTree Reveals European ETF Growth Drivers Over the Next Decade as it Celebrates 10 Years in Europe
-
FinThrive® Achieves Claims Management Certification for Oracle Health Patient Accounting
-
Matica Biotechnology Establishes CDMO Partnership with KaliVir Immunotherapeutics
-
Edmonton MedTech Start-Up MACH32 Awarded Research and Development Contract From BARDA To Develop Life-Saving Bleeding Control Intervention
-
BioIVT to Highlight New Ki67 Tissue Staining Service at Biomarkers U.S. 2024 and The Society for Immunotherapy of Cancer (SITC) 2024
-
a.k.a. Brands Holding Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
-
Leading Technology Provider Bentek Selected for BenefitsPRO's 2024 Luminaries Award
-
ABM and Mainspring Energy Sign Strategic Partnership
-
Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting
-
NANO Nuclear Energy Announces Pricing of Upsized $36 Million Underwritten Offering
-
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
-
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
